NeuroMetrix, Inc. Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a health care company transforming patient care through neurotechnology, today announced that the Compensation Committee of NeuroMetrix's Board of Directors granted of an inducement stock option to purchase up to 100,000 shares of common stock to Walter Christensen, its newly appointed Senior Vice President, Global Sales, on May 4, 2009.
MORE ON THIS TOPIC